Skip to main content
Erschienen in: Journal of General Internal Medicine 6/2019

18.03.2019 | Original Research

Real-world Performance of Meta-analysis Methods for Double-Zero-Event Studies with Dichotomous Outcomes Using the Cochrane Database of Systematic Reviews

verfasst von: Yanan Ren, PhD, Lifeng Lin, PhD, Qinshu Lian, PhD, Hui Zou, PhD, Haitao Chu, MD, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Meta-analysis combines multiple independent studies, which can increase power and provide better estimates. However, it is unclear how best to deal with studies with zero events; such studies are also known as double-zero-event studies (DZS). Several statistical methods have been proposed, but the agreement among different approaches has not been systematically assessed using real-world published systematic reviews.

Methods

The agreement of five commonly used methods (i.e., the inverse-variance, Mantel–Haenszel, Peto, Bayesian, and exact methods) was assessed using the Cohen’s κ coefficients using 368 meta-analyses with rare events selected from the Cochrane Database of Systematic Reviews. Three continuity corrections, including the correction of a constant 0.5, the treatment arm continuity correction (TACC), and the empirical (EMP) correction, were used to handle DZS when applying inverse-variance and Mantel–Haenszel methods.

Results

When the proportion of DZS studies was lower than 50% in a meta-analysis, different methods had moderately high agreement. However, when this proportion was increased to be over 50%, the agreement among the methods decreased to different extents. For the Bayesian, exact, and Peto methods and the inverse-variance and Mantel–Haenszel methods using the EMP correction, their agreement coefficients with the inverse-variance and Mantel–Haenszel methods using a constant 0.5 and TACC decreased from larger than 0.70 to smaller than 0.30. In contrast, the agreement coefficients only decreased slightly among the Bayesian, exact, and Peto methods and the inverse-variance and Mantel–Haenszel methods using the EMP correction.

Conclusions

To utilize all available information and reduce research waste and avoid overestimating the effect, meta-analysts should incorporate DZS, rather than simply removing them. The Peto and other conventional methods with continuity correction should be avoided when the proportion of DZS is extremely high. The exact and Bayesian methods are highly recommended, except when none of the included studies have an event in one or both treatment arms.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
3.
Zurück zum Zitat Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis. Wiley, New York; 2009.CrossRef Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis. Wiley, New York; 2009.CrossRef
4.
Zurück zum Zitat Sutton AJ, Cooper NJ, Lambert PC, Jones DR, Abrams KR, Sweeting MJ. Meta-analysis of rare and adverse event data. Expert Rev Pharmacoecon Outcomes Res. 2002;2(4):367–379.CrossRefPubMed Sutton AJ, Cooper NJ, Lambert PC, Jones DR, Abrams KR, Sweeting MJ. Meta-analysis of rare and adverse event data. Expert Rev Pharmacoecon Outcomes Res. 2002;2(4):367–379.CrossRefPubMed
5.
Zurück zum Zitat Tian L, Cai TX, Pfeffer MA, Piankov N, Cremieux PY, Wei LJ. Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction. Biostatistics. 2009;10(2):275–281.CrossRefPubMed Tian L, Cai TX, Pfeffer MA, Piankov N, Cremieux PY, Wei LJ. Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction. Biostatistics. 2009;10(2):275–281.CrossRefPubMed
7.
Zurück zum Zitat Liu D, Liu RY, Xie M. Exact meta-analysis approach for discrete data and its application to 2 x 2 tables with rare events. J Am Stat Assoc. 2014;109(508):1450–1465.CrossRefPubMedPubMedCentral Liu D, Liu RY, Xie M. Exact meta-analysis approach for discrete data and its application to 2 x 2 tables with rare events. J Am Stat Assoc. 2014;109(508):1450–1465.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Yang G, Liu D, Wang J, Xie MG. Meta-analysis framework for exact inferences with application to the analysis of rare events. Biometrics. 2016;72(4):1378–1386.CrossRefPubMed Yang G, Liu D, Wang J, Xie MG. Meta-analysis framework for exact inferences with application to the analysis of rare events. Biometrics. 2016;72(4):1378–1386.CrossRefPubMed
9.
Zurück zum Zitat Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23:1351–1375.CrossRefPubMed Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23:1351–1375.CrossRefPubMed
10.
Zurück zum Zitat Bradburn MJ, Deeks JJ, Berlin JA, Localio AR. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med. 2007;26(1):53–77.CrossRefPubMed Bradburn MJ, Deeks JJ, Berlin JA, Localio AR. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med. 2007;26(1):53–77.CrossRefPubMed
11.
Zurück zum Zitat Cheng J, Pullenayegum E, Marshall JK, Iorio A, Thabane L. Impact of including or excluding both-armed zero-event studies on using standard meta-analysis methods for rare event outcome: a simulation study. BMJ Open. 2016;6(8):e010983.CrossRefPubMedPubMedCentral Cheng J, Pullenayegum E, Marshall JK, Iorio A, Thabane L. Impact of including or excluding both-armed zero-event studies on using standard meta-analysis methods for rare event outcome: a simulation study. BMJ Open. 2016;6(8):e010983.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Chalmers I, Bracken MB, Djulbegovic B, et al. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383(9912):156–165.CrossRefPubMed Chalmers I, Bracken MB, Djulbegovic B, et al. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383(9912):156–165.CrossRefPubMed
13.
Zurück zum Zitat Smith TC, Spiegelhalter DJ, Thomas A. Bayesian approaches to random-effects meta-analysis: a comparative study. Stat Med. 1995;14(24):2685–2699.CrossRefPubMed Smith TC, Spiegelhalter DJ, Thomas A. Bayesian approaches to random-effects meta-analysis: a comparative study. Stat Med. 1995;14(24):2685–2699.CrossRefPubMed
14.
Zurück zum Zitat Bai O, Chen M, Wang X. Bayesian Estimation and Testing in Random Effects Meta-analysis of Rare Binary Adverse Events. Stat Biopharm Res. 2016;8(1):49–59.CrossRefPubMed Bai O, Chen M, Wang X. Bayesian Estimation and Testing in Random Effects Meta-analysis of Rare Binary Adverse Events. Stat Biopharm Res. 2016;8(1):49–59.CrossRefPubMed
15.
Zurück zum Zitat Rucker G, Schwarzer G, Carpenter J, Olkin I. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. Stat Med. 2009;28(5):721–738.CrossRefPubMed Rucker G, Schwarzer G, Carpenter J, Olkin I. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. Stat Med. 2009;28(5):721–738.CrossRefPubMed
16.
Zurück zum Zitat Egger M, Smith GD, Phillips AN. Meta-analysis: Principles and procedures. Br Med J. 1997;315(7121):1533–1537.CrossRef Egger M, Smith GD, Phillips AN. Meta-analysis: Principles and procedures. Br Med J. 1997;315(7121):1533–1537.CrossRef
17.
Zurück zum Zitat Grimes DA, Schulz KF. Making sense of odds and odds ratios. Obstet Gynecol. 2008;111(2):423–426.CrossRefPubMed Grimes DA, Schulz KF. Making sense of odds and odds ratios. Obstet Gynecol. 2008;111(2):423–426.CrossRefPubMed
18.
Zurück zum Zitat Cohen J. A Coefficient of Agreement for Nominal Scales. Educ Psychol Meas. 1960;20(1):37–46.CrossRef Cohen J. A Coefficient of Agreement for Nominal Scales. Educ Psychol Meas. 1960;20(1):37–46.CrossRef
19.
Zurück zum Zitat Leucht C, Kitzmantel M, Chua L, Kane J, Leucht S. Haloperidol versus chlorpromazine for treatment of schizophrenia. Schizophr Bull. 2008;34(5):813–815.CrossRefPubMedPubMedCentral Leucht C, Kitzmantel M, Chua L, Kane J, Leucht S. Haloperidol versus chlorpromazine for treatment of schizophrenia. Schizophr Bull. 2008;34(5):813–815.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Springate DA, Kontopantelis E. Cochrane_scraper: tools for downloading data from the Cochrane Library of Systematic Reviews. 2014:Version 1.1.0. Springate DA, Kontopantelis E. Cochrane_scraper: tools for downloading data from the Cochrane Library of Systematic Reviews. 2014:Version 1.1.0.
21.
Zurück zum Zitat Marodin G, Goldim JR. Confusions and Ambiguities in the Classification of Adverse Events in the Clinical Research. Revista Da Escola De Enfermagem Da Usp 2009;43(3):690–696.CrossRef Marodin G, Goldim JR. Confusions and Ambiguities in the Classification of Adverse Events in the Clinical Research. Revista Da Escola De Enfermagem Da Usp 2009;43(3):690–696.CrossRef
22.
Zurück zum Zitat Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–748.PubMed Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–748.PubMed
23.
Zurück zum Zitat Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial-infarction - an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27(5):335–371.CrossRefPubMed Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial-infarction - an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27(5):335–371.CrossRefPubMed
24.
Zurück zum Zitat Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. , Chichester: John Wiley & Sons; 2008.CrossRef Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. , Chichester: John Wiley & Sons; 2008.CrossRef
26.
Zurück zum Zitat Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, Sterne JAC. metan: fixed- and random-effects meta-analysis. Stata J. 2008;8(1):3–28.CrossRef Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, Sterne JAC. metan: fixed- and random-effects meta-analysis. Stata J. 2008;8(1):3–28.CrossRef
27.
Zurück zum Zitat Greenland S, Salvan A. Bias in the one-step method for pooling study results. Stat Med. 1990;9(3):247–252.CrossRefPubMed Greenland S, Salvan A. Bias in the one-step method for pooling study results. Stat Med. 1990;9(3):247–252.CrossRefPubMed
28.
Zurück zum Zitat DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.CrossRefPubMed DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.CrossRefPubMed
30.
Zurück zum Zitat Lane PW. Meta-analysis of incidence of rare events. Stat Methods Med Res. 2013;22(2):117–132.CrossRefPubMed Lane PW. Meta-analysis of incidence of rare events. Stat Methods Med Res. 2013;22(2):117–132.CrossRefPubMed
31.
Zurück zum Zitat Landis JR, Koch GG. Measurement of Observer Agreement for Categorical Data. Biometrics. 1977;33(1):159–174.CrossRef Landis JR, Koch GG. Measurement of Observer Agreement for Categorical Data. Biometrics. 1977;33(1):159–174.CrossRef
32.
Zurück zum Zitat Friedrich JO, Adhikari NK, Beyene J. Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data. BMC Med Res Methodol. 2007; 7 (5). Friedrich JO, Adhikari NK, Beyene J. Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data. BMC Med Res Methodol. 2007; 7 (5).
33.
Zurück zum Zitat Rhodes S. Publication bias in meta-analysis. J R Stat Soc A Stat Soc. 2006;169:1012–1012.CrossRef Rhodes S. Publication bias in meta-analysis. J R Stat Soc A Stat Soc. 2006;169:1012–1012.CrossRef
34.
Zurück zum Zitat Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2017;74(3):785–794. Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2017;74(3):785–794.
35.
Zurück zum Zitat Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol. 2000;53(2):207–216.CrossRefPubMed Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol. 2000;53(2):207–216.CrossRefPubMed
36.
Zurück zum Zitat Shrier I, Boivin J-F, Steele RJ, et al. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? a critical examination of underlying principles. Am J Epidemiol. 2007;166(10):1203–1209.CrossRefPubMed Shrier I, Boivin J-F, Steele RJ, et al. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? a critical examination of underlying principles. Am J Epidemiol. 2007;166(10):1203–1209.CrossRefPubMed
37.
Zurück zum Zitat Golder S, Loke YK, Bland M. Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview. PLoS Med. 2011;8:e1001026.CrossRefPubMedPubMedCentral Golder S, Loke YK, Bland M. Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview. PLoS Med. 2011;8:e1001026.CrossRefPubMedPubMedCentral
Metadaten
Titel
Real-world Performance of Meta-analysis Methods for Double-Zero-Event Studies with Dichotomous Outcomes Using the Cochrane Database of Systematic Reviews
verfasst von
Yanan Ren, PhD
Lifeng Lin, PhD
Qinshu Lian, PhD
Hui Zou, PhD
Haitao Chu, MD, PhD
Publikationsdatum
18.03.2019
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 6/2019
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-04925-8

Weitere Artikel der Ausgabe 6/2019

Journal of General Internal Medicine 6/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.